AI assistant
Witan Investment Trust PLC — Director's Dealing 2018
Dec 21, 2018
5244_dirs_2018-12-21_d89abe13-1cef-4733-8053-c765663a6cb6.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2856L
Witan Investment Trust PLC
21 December 2018
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Jack Scott Perry
2
Reason for the notification
a)
Position/status
Non-executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Witan Investment Trust plc
b)
LEI
213800XMW68XFT6D1X59
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 25p each
GB0009744060
b)
Nature of the transaction
Acquisition of shares (dividend reinvestment)
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 965.5 pence per share | 33 |
d)
Aggregated information
- Aggregated volume
- Price
33 ordinary 25p shares
965.5 pence per share
e)
Date of the transaction
20 December 2018
f)
Place of the transaction
London Stock Exchange (XLON)
Name of authorised official of issuer responsible for making notification:
Eleanor Cranmer, for and on behalf of Frostrow Capital LLP
Company Secretary to WITAN INVESTMENT TRUST PLC
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFEEFFFFASEEE